Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leandro L, Coutinho"'
Autor:
Leandro L. Coutinho, Elise L. Femino, Ana L. Gonzalez, Rebecca L. Moffat, William F. Heinz, Robert Y. S. Cheng, Stephen J. Lockett, M. Cristina Rangel, Lisa A. Ridnour, David A. Wink
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 6103 (2024)
Nitric oxide (NO) and reactive nitrogen species (RNS) exert profound biological impacts dictated by their chemistry. Understanding their spatial distribution is essential for deciphering their roles in diverse biological processes. This review establ
Externí odkaz:
https://doaj.org/article/e28a6f3cac1d4af7b9d15e9f8abda74f
Autor:
Alexandre Cesar Vieira, Sales, Isaura Isabelle Fonseca, Gomes da Silva, Matheus C B, Leite, Leandro L, Coutinho, Renata B A C, Reis, Angela, Castoldi, Danyelly, Bg Martins, José Luiz, Lima-Filho, Fabricio Oliveira, Souto
Publikováno v:
Breast Cancer : Targets and Therapy
Introduction MicroRNA-21 (miRNA-21) has been described as one of the most significantly upregulated miRNAs in human breast cancer. However, limited knowledge exists on miRNA-21 expression in breast cancer tissue after neoadjuvant chemotherapy (NAC).
Autor:
Ridnour LA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Heinz WF; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Cheng RY; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Wink AL; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Kedei N; Collaborative Protein Technology Resource (CPTR) Nanoscale Protein Analysis, OSTR, CCR, NCI, NIH., Pore M; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research., Imtiaz F; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Femino EL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Gonzalez AL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Coutinho L; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Butcher D; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Rangel MC; Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Kinders RJ; Office of the Director, Division of Cancer Treatment and Diagnosis, NCI, Frederick, MD., Lipkowitz S; Women's Malignancies Branch, CCR, NCI, NIH., Wong ST; Houston Methodist Weill Cornell Medical College, Houston TX., Anderson SK; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., McVicar DW; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA., Glynn SA; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Billiar TR; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA., Chang JC; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX., Hewitt SM; Laboratory of Pathology CCR, NCI, NIH., Ambs S; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD., Lockett SJ; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Wink DA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.
Autor:
Ridnour LA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Cheng RYS; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Heinz WF; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Pore M; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research., Gonzalez AL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Femino EL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Moffat R; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Wink AL; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Imtiaz F; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Coutinho L; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Butcher D; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Rangel MC; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Wong STC; Houston Methodist Weill Cornell Medical College, Houston TX., Lipkowitz S; Women's Malignancies Branch, CCR, NCI, NIH., Glynn S; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Vitek MP; (Mike Duke)., McVicar DW; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA., Anderson SK; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Basic Science Program, Frederick National Laboratory for Cancer Research., Paolocci N; Division of Cardiology, Department of Medicine, Johns Hopkins University, and Department of Biomedical Sciences, University of Padova, Italy.; Laboratory of Pathology CCR, NCI, NIH., Hewitt SM; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD., Ambs S; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA., Billiar TR; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX., Chang JC; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD.; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research.; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil.; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute.; Houston Methodist Weill Cornell Medical College, Houston TX.; Women's Malignancies Branch, CCR, NCI, NIH.; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland.; (Mike Duke).; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA.; Basic Science Program, Frederick National Laboratory for Cancer Research.; Division of Cardiology, Department of Medicine, Johns Hopkins University, and Department of Biomedical Sciences, University of Padova, Italy.; Laboratory of Pathology CCR, NCI, NIH.; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD.; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX., Lockett SJ; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Wink DA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.
Autor:
Cheng RYS; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Ridnour LA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Wink AL; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA., Gonzalez AL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Femino EL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Rittscher H; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Somasundaram V; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Heinz WF; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA., Coutinho L; Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de São Paulo; and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Rangel MC; Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de São Paulo; and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for NCI, Frederick, MD, USA., Butcher D; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for NCI, Frederick, MD, USA., Kinders RJ; Office of the Director, Division of Cancer Treatment and Diagnosis, NCI, Frederick, MD, USA., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Wong STC; Systems Medicine and Bioengineering Department, Houston Methodist Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX, USA., McVicar DW; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Anderson SK; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA., Pore M; Imaging Mass Cytometry Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hewitt SM; Laboratory of Pathology CCR, NCI, NIH, Bethesda, MD, USA., Billiar TR; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA., Glynn SA; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Chang JC; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX, USA., Lockett SJ; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD, USA., Ambs S; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD, USA., Wink DA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. wink@mail.nih.gov.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 May 11; Vol. 14 (5), pp. 319. Date of Electronic Publication: 2023 May 11.
Autor:
Cheng RY, Ridnour LA, Wink AL, Gonzalez AL, Femino EL, Rittscher H, Somasundarum V, Heinz WF, Coutinho L, Cristina Rangel M, Edmondson EF, Butcher D, Kinders RJ, Li X, Wong STC, McVicar DW, Anderson SK, Pore M, Hewitt SM, Billiar TR, Glynn S, Chang JC, Lockett SJ, Ambs S, Wink DA
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 06. Date of Electronic Publication: 2023 Apr 06.